Login

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

DOI: 10.1158/0008-5472.23683824 Publication Date: 2023-07-14T08:20:28Z
Abstract Supplemental Material References Cited by
AUTHORS (48)
Evangeline R. Jac...
Ryan J. Duchatel
Dilana E. Staudt
Mika L. Persson
Abdul Mannan
Sridevi Yadavilli
Sarah Parackal
Shaye Game
Wai Chin Chong
W. Samantha N. Ja...
Marion Le Grand
Padraic S. Kearney
Alicia M. Douglas
Izac J. Findlay
Zacary P. Germon
Holly P. McEwen
Tyrone S. Beitaki
Adjanie Patabendige
David A. Skerrett...
Brett Nixon
Nathan D. Smith
Bryan Day
Neevika Manoharan
Sumanth Nagabushan
Jordan R. Hansford
Dinisha Govender
Geoff B. McCowage
Ron Firestein
Meegan Howlett
Raelene Endersby
Nicholas G. Gottardo
Frank Alvaro
Sebastian M. Waszak
Martin R. Larsen
Yolanda Colino-Sa...
Fatima Valdes-Mora
Andria Rakotomalala
Samuel Meignan
Eddy Pasquier
Nicolas André
Esther Hulleman
David D. Eisenstat
Nicholas A. Vitanza
Javad Nazarian
Carl Koschmann
Sabine Mueller
Jason E. Cain
Matthew D. Dun
ABSTRACT
<p>All Supplementary Tables</p>
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
OPENAIRE - Products  CROSSREF - Publications 
PlumX Metrics
Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma 
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....

Powered by

  • AIX SEMS NFDI4DS

Legal

  • Impressum Datenschutz

Connect